Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

F.D.A. Approves a New Antipsychotic Drug

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

Ellen Barry
Author: Ellen Barry

Written by

Ellen Barry

in

Clinical Trials, Dopamine, Drugs (Pharmaceuticals), Food and Drug Administration, Karuna Therapeutics Inc, Psychiatry and Psychiatrists, Psychology and Psychologists, Regulation and Deregulation of Industry, Research, Schizophrenia, Therapy and Rehabilitation
←Museum at FIT Tells the Story of the African Diaspora Through Its Fashions
Inside the U.N. Dinner Party at Eleven Madison Park→

More posts

  • Met chief accepts mistakes made over Simon Levy but defends investigation into murders

  • Paul Anthony Kelly Has Found a New Love Story as…a Disney Weddings Model

  • Venice Drama ‘I Matter’, About Roma Experience, Gets Sales Deal

  • Critical former referees add to culture of fear, says retiring Taylor

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube